ELI LILLY & CO (LLY)
Clinical trial NCT03363464 updates: 1. completion date: 2026-05-31 → 2026-06-30 2. primary completion date: 2026-05-31 → 2026-06-30
Clinical trial NCT03363464 updates: 1. completion date: 2026-05-31 → 2026-06-30 2. primary completion date: 2026-05-31 → 2026-06-30
Clinical trial NCT05720325: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT07416994 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-03-06 → 2026-03-18
Clinical trial NCT07108166 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. enrollment type: ACTUAL → ESTIMATED
Clinical trial NCT03152214 updates: 1. collaborators added: Team RWB 2. collaborators removed: Team Red, White, and Blue
Clinical trial NCT07334860 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-28 → 2026-05-20 3. primary completion date: 2026-05-28 → 2026-05-20 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07490431 updates: 1. start date: 2026-06-30 → 2026-11-02 2. completion date: 2029-06-30 → 2029-11-02 3. primary completion date: 2029-06-30 → 2029-11-02
Clinical trial NCT06983743: collaborators added: Merck Sharp & Dohme LLC.
Clinical trial NCT07607054: status: NOT_YET_RECRUITING → RECRUITING.
Clinical trial NCT07422480: start date: 2026-04-01 → 2026-05-21.